Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine for Hot Flashes in Women on Tamoxifen for Hormone Receptor-Positive Breast Cancer (HOFLA-V)
jRCTs031220435Active, not recruiting
- Sponsor
- University of Tsukuba Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of venlafaxine in hot flash and vasomotor symptoms, sponsored by University of Tsukuba Hospital. Primary endpoint: Primary: Change in hot flash score from baseline to week 4. Started Dec 2022; status: active, not recruiting.
02
Drugs
venlafaxine
03
Conditions
hot flashvasomotor symptoms
Beyond the preview
Go deeper on jRCTs031220435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220435.